Product Description

Ponaxen Tablets 45mg contains Ponatinib, a tyrosine kinase inhibitor used to treat certain Philadelphia chromosome-positive leukemias.

Product Overview

Product Name: Ponaxen Tablets 45mg

Generic Name: Ponatinib

Strength: 45mg

Form: Tablets

Pack Size: As per manufacturer packaging

Used For: Selected Philadelphia chromosome-positive leukemias

Prescription Required: Yes

Ingredients & How They Work

Each tablet contains Ponatinib 45mg, which inhibits BCR-ABL and other tyrosine kinases involved in the growth of abnormal leukemia cells.

Key Benefits

• Used in selected CML
• Used in certain Philadelphia chromosome-positive ALL
• Targets BCR-ABL activity
• Effective against certain resistant mutations
• Oral targeted therapy

How to Use

Take exactly as prescribed by your oncologist. Swallow whole with water and follow the prescribed treatment schedule.

Side Effects & Precautions

Possible Side Effects

• High blood pressure
• Fatigue
• Rash
• Abdominal pain
• Low blood cell counts

Precautions

• Can cause serious arterial and venous blood-vessel complications.
• Cardiovascular monitoring is important.
• Report chest pain, breathing difficulty, sudden weakness, or severe headache immediately.
• Use only under specialist supervision.

Storage Instructions

Store below 30°C in a cool, dry place away from moisture and direct sunlight.